Cleared is not adopted. Piloted is not purchased. Funded is not fielded.
Healthcare technology does not fail because the science is wrong. It fails at the last mile, where a validated product meets a clinical workflow, a payment mechanism, a regulator, and a buyer with neither the budget nor the organisational capacity to deploy it.
Investment Philosophy
Adoption is the alpha
Most healthcare AI funds underwrite technology risk. Does the algorithm perform in a controlled environment?
We underwrite adoption risk. Will this technology survive the environments it actually has to live in?
In healthcare AI, the models mostly work. The scarce and differentiated skill is accelerating adoption. Returns in this category are created during the period when adoption is being proven, before outcomes are visible to the wider market.
“In Healthcare AI, adoption is not the last mile. It is the whole business.”
Dr. Mohammed Quadri, MD, MBA Founder & General Partner, GrowQ360
“In Healthcare AI, adoption is not the last mile. It is the whole business.”
Dr. Mohammed Quadri, MD, MBA | Founder & General Partner, GrowQ360
Four questions decide every investment
Gap
The unmet clinical need. Consequential, urgent, and unresolved today.
Resolution
Whether the company resolves that need in real time, rapidly and accurately, at the point of care rather than in retrospect.
Onramp
Whether it can enter and scale inside real health systems.
Worth
Whether adoption converts into durable revenue and lasting value.
Innovation alone creates nothing. Capital alone creates nothing. Adoption alone creates nothing. Value exists only where all three are bound together.
We underwrite adoption across five dimensions
Clinical workflow fit
Whether the product integrates into existing practice without disrupting it.
Reimbursement pathway
Whether a payment route exists, or whether payers are being asked to change behaviour.
Regulatory alignment
Whether it sits inside existing FDA, CMS and international frameworks.
Buyer readiness
Whether the buyer has the data infrastructure, budget authority and organisational capacity to implement.
Cross-market transferability
Whether adoption in one system predicts adoption in the next.
A superb model with no route to deployment and payment does not clear the screen.
Companies that score across all five are not always the most technically advanced. They are the most deployable.
Our Approach
Our investment process
Identify
Revenue-generating healthcare AI and digital health companies at Seed and Series A, addressing consequential healthcare problems, with demonstrated commercial traction and the potential for adoption at scale.
Assess
Technology, market opportunity, competitive positioning, team quality and adoption readiness.
Underwrite
The clinical, operational and health-system factors that determine whether a product is used, paid for and kept
Invest
In businesses positioned to create enduring enterprise value.
Why GrowQ360
Physician-led underwriting
Investment decisions made by clinicians who have sat on the buyer’s side of the table.
Operator experience inside health systems
Two decades of senior health-system leadership across strategy, ambulatory growth, research and innovation.
Adoption-focused diligence
Every company is assessed against the clinical, operational and economic factors that determine real-world uptake.
Clinical adoption leadership
A dedicated Chief Clinical Adoption Officer drawn from three decades of nursing and clinical-operations leadership at major academic health systems.
Healthcare AI specialisation
A single category studied closely, rather than a generalist portfolio with a healthcare allocation.
Global adoption pathways
Active relationships across the United States, the United Kingdom, Türkiye, the Middle East, Africa and Europe, including NHS clinical and governance requirements.
Who we Serve
Built for the healthcare innovation economy
Limited Partners
A differentiated healthcare AI thesis underwritten by clinicians and operators.
Founders
Capital from investors who understand procurement, governance and clinical workflow from the inside.
Co-Investors
High-conviction healthcare opportunities shaped by disciplined diligence.
Strategic Partners
A network of investors, clinicians, operators and industry leaders advancing healthcare innovation.
What we do not claim
There are no realised exits. GrowQ360 is a first-time institutional fund and says so plainly.
Company-provided metrics are labelled as such and are not independently verified. Platform capabilities in beta are described as beta.
The Fund has not yet begun investing. Companies shown reflect the General Partner’s sourcing, special purpose vehicles and pipeline, and are not current Fund holdings.
Any investor who requires a realised track record should not proceed, and we would rather say that here than three meetings from now.
Invest in the Future of Healthcare AI
Partner with a venture fund that treats adoption as the driver of growth, value creation and long-term outcomes.
Innovate. Invest. Adopt.
